CoCensys Posts $4.1-Million Quarterly Loss
CoCensys Inc., the Irvine pharmaceutical company, reported a third-quarter loss of $4.1 million, or 30 cents a share, for the quarter ended Sept. 30. For the same quarter last year, the company recorded a loss of $2.6 million or 28 cents a share.
The company reported revenues of $1.6 million, up from no revenue during the 1993 third quarter. Nine-month losses totaled $24.8 million, or $2.31 a share, compared with losses of $7.3 million, or 84 cents a share, for the first nine months of 1993. Revenue for the first nine months totaled $1.6 million, up from no revenues in the first nine months of 1993.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.